Literature DB >> 22975656

Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.

S Ling1, Q Li, H Lin, W Li, T Wang, H Ye, J Yang, X Jia, Y Sun.   

Abstract

PURPOSE: To compare lymphangiogenesis in primary versus recurrent pterygium.
METHODS: Tissues from 88 excised primary and 34 recurrent pterygia were evaluated, and tissues from 7 nasal epibulbar conjunctivae segments were used as controls. The lymph-vascular area (LVA), lymph-microvascular density (LMD), and lymph-vascular luminal diameter (LVL) were examined and compared between the primary and recurrent pterygia. In addition, the expression of VEGF-A and VEGF-C in the primary and recurrent pterygia were determined by ELISA and real-time PCR. The relationships between the mRNA level and LVA, LMD, and LVL were clarified.
RESULTS: Although there was no significant difference in quantification of LVL between primary and recurrent pterygia, the quantification of LVA and LMD in recurrent pterygia dramatically increased in comparison with primary pterygia (both P-values <0.01). Compared with primary pterygia, the VEGF-A and VEGF-C mRNA levels were up-regulated significantly in recurrent pterygia (both P-values <0.05). There was a significant relationship between VEGF-C mRNA and LVA, LMD, and LVL, while VEGF-A mRNA was only closely correlated with LMD in recurrent pterygia.
CONCLUSIONS: Lymphangiogenesis develops in recurrent pterygium, for which transient up-regulation of VEGF-C might be responsible.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975656      PMCID: PMC3496107          DOI: 10.1038/eye.2012.194

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Authors:  Jürgen Becker; Helena Pavlakovic; Fabian Ludewig; Fabiola Wilting; Herbert A Weich; Romulo Albuquerque; Jayakrishna Ambati; Jörg Wilting
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 2.  Corneal lymphangiogenesis: implications in immunity.

Authors:  Sangita P Patel; Reza Dana
Journal:  Semin Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.975

3.  Role of periostin and interleukin-4 in recurrence of pterygia.

Authors:  Chuan-Hui Kuo; Dai Miyazaki; Keiko Yakura; Kaoru Araki-Sasaki; Yoshitsugu Inoue
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

4.  Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.

Authors:  Kentaro Kajiya; Satoshi Hirakawa; Michael Detmar
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.

Authors:  Tina Dietrich; Felix Bock; Don Yuen; Deniz Hos; Björn O Bachmann; Grit Zahn; Stanley Wiegand; Lu Chen; Claus Cursiefen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

6.  VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  J Exp Med       Date:  2009-12-21       Impact factor: 14.307

7.  Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed.

Authors:  Shiqi Ling; Caoxiu Qi; Wei Li; Jiangang Xu; Wenghui Kuang
Journal:  Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 4.207

8.  Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.

Authors:  B O Bachmann; E Luetjen-Drecoll; F Bock; S J Wiegand; D Hos; R Dana; F E Kruse; C Cursiefen
Journal:  Br J Ophthalmol       Date:  2009-02-17       Impact factor: 4.638

9.  Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.

Authors:  Felix Bock; Jasmine Onderka; Tina Dietrich; Björn Bachmann; Bronislaw Pytowski; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-02       Impact factor: 3.117

10.  Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.

Authors:  Kentaro Kajiya; Mika Sawane; Reto Huggenberger; Michael Detmar
Journal:  J Invest Dermatol       Date:  2008-11-13       Impact factor: 8.551

View more
  9 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

Review 2.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

3.  A novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty.

Authors:  H B Cakmak; G Dereli Can; M E Can; N Cagil
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

4.  Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin).

Authors:  Noha Ghoz; John Britton; Andrew R Ross; Imran Mohammed; Emily Hogan; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2019-06-19       Impact factor: 3.775

Review 5.  The Role of Limbal Epithelial Stem Cells in Regulating Corneal (Lymph)angiogenic Privilege and the Micromilieu of the Limbal Niche following UV Exposure.

Authors:  M Notara; A Lentzsch; M Coroneo; C Cursiefen
Journal:  Stem Cells Int       Date:  2018-05-08       Impact factor: 5.443

6.  UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation.

Authors:  M Notara; S Behboudifard; M A Kluth; C Maßlo; C Ganss; M H Frank; B Schumacher; C Cursiefen
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

7.  Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study.

Authors:  Mingyang Yin; Hang Li; Yingnan Zhang; Honglei Dai; Fei Luo; Zhiqiang Pan
Journal:  Cornea       Date:  2019-10       Impact factor: 2.651

Review 8.  Recurrent Pterygium: A Review.

Authors:  Leila Ghiasian; Bijan Samavat; Yasaman Hadi; Mona Arbab; Navid Abolfathzadeh
Journal:  J Curr Ophthalmol       Date:  2022-01-06

9.  Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia.

Authors:  Wei Zhao; Tao Wang; Juan Deng; Lei Zhong; Weilan Huang; Shiqi Ling
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.